All In Biotech

Free tool

FAERS Monitor: Strensiq

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming BLA 125513 or its brand name (Strensiq, Asfotase Alfa). Reports on generic versions are filed under their own applications.

Reports

10,322

Serious

3,394

33% of reports

Hospitalization

799

Death reported

79

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • injection site pain1,351
  • fatigue1,029
  • injection site erythema881
  • pain851
  • injection site reaction778
  • arthralgia713
  • pain in extremity564
  • injection site bruising513
  • injection site swelling442
  • headache416
  • injection site pruritus344
  • bone pain323
  • blood alkaline phosphatase increased319
  • nausea313
  • malaise307

Reports by year received

View as table
YearReports
201533
2016785
20171,088
20181,301
20191,057
2020259
2021206
2022172
2023714
20242,432
20251,084
20261,191

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,043,837 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
blood alkaline phosphatase increasedSignal31926.523.87,716
injection site reactionSignal77823.321.816,442
injection site erythemaSignal88114.613.711,106
injection site bruisingSignal51313.212.15,748
injection site swellingSignal44211.810.84,356
bone painSignal32311.310.13,012
injection site pruritusSignal34410.59.52,946
injection site painSignal1,3519.08.69,712
pain in extremitySignal5643.93.61,231
arthralgiaSignal7133.53.31,293
painSignal8512.82.61,031
fatigueSignal1,0292.72.51,136
malaise3071.41.340
headache4161.41.239
nausea3130.80.715

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.